Department of Obstetrics, Gynecology, & Reproductive Sciences, School of Medicine, Yale University, PO Box 208063, New Haven, CT 06520-8063, United States.
Department of Pediatrics, School of Medicine, Yale University, P.O. Box 208064, New Haven, CT 06520-8064, United States; Department of Investigative Medicine, School of Medicine, Yale University, 2 Church Street South, Suite 114, New Haven, CT 06519, United States.
Vaccine. 2018 Jun 14;36(25):3599-3605. doi: 10.1016/j.vaccine.2018.05.039. Epub 2018 May 11.
HPV vaccine uptake is lowest among young adults. Little is known about the most effective way to decrease missed opportunities (MO) and increase uptake of the vaccine in this vulnerable population.
To determine the impact of a clinical intervention bundle on the rate of MO and uptake of the vaccine among young adult women.
From 2/2014 to 7/2015, an intervention bundle (designating physician and nurse champions, pre-screening patients' charts, empowering nurses to recommend immunization, providing no-cost vaccinations, placing prompts in clinic note templates, eliminating requirement for pre-vaccination pregnancy test) was implemented at an urban, hospital-based OB/GYN clinic. Medical records were reviewed for all vaccine-eligible (non-pregnant, 11-26 years) women seen between 2/2013 and 9/2016. Impact of the bundled interventions on the monthly rates of MO and vaccine uptake was estimated by analyzing immunization trends with an interrupted time-series model using counterfactual comparison groups in order to control for pre-existing trends.
There were 6,463 vaccine-eligible visits during our study period. The prevalence of women who had both completed and initiated the series was significantly higher, 20.3% and 29.7% respectively, in the last month, compared to their counterfactuals (p < 0.01). In the last study month, the rate of MO was significantly lower than its counterfactual (19.73 per 100 encounters lower, p < 0.01). Hispanic women had attributable reductions in their rates of MO that were twice that of White women. Statistically significant attributable reductions were also seen among Spanish speakers, publicly insured, and uninsured women.
Implementation of this intervention bundle effectively reduced the monthly rate of MO and increased the prevalence of women who had initiated and completed the HPV vaccine series. The reduction of MO was most drastic among Hispanic, publicly insured and uninsured women compared to White and privately insured.
HPV 疫苗接种率在年轻人中最低。对于如何减少这一脆弱人群的错失机会(MO)并提高疫苗接种率,我们知之甚少。
确定临床干预措施包对年轻女性 MO 发生率和疫苗接种率的影响。
2014 年 2 月至 2015 年 7 月,在一家城市妇产科医院实施了一套干预措施(指定医生和护士为倡导者,预先筛选患者病历,授权护士推荐免疫接种,提供免费疫苗接种,在诊所记录模板中设置提示,取消接种前妊娠试验要求)。对 2013 年 2 月至 2016 年 9 月期间所有符合疫苗接种条件(非孕妇,年龄 11-26 岁)的女性的病历进行了回顾。通过使用中断时间序列模型分析免疫接种趋势,并采用对照比较组进行虚假比较,以控制预先存在的趋势,来估计捆绑干预措施对每月 MO 和疫苗接种率的影响。
在我们的研究期间,共有 6463 名符合疫苗接种条件的就诊者。与对照组相比,在最后一个月中,已经完成和开始接种系列疫苗的女性比例分别显著更高,分别为 20.3%和 29.7%(p<0.01)。在最后一个研究月,MO 发生率明显低于对照组(每 100 次就诊减少 19.73 次,p<0.01)。西班牙裔女性的 MO 发生率降低幅度是白人女性的两倍。西班牙语使用者、公共保险和无保险女性的发病率也有显著降低。
实施该干预措施包可有效降低 MO 的月发生率并增加开始和完成 HPV 疫苗系列接种的女性比例。与白人及私人保险女性相比,西班牙裔、公共保险和无保险女性的 MO 减少幅度最大。